Hemophilia A Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 28
SKU : PH6801
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
FAQ’s
What is the Projected CAGR value of the Hemophilia A Treatment Market ?
Hemophilia A Treatment Market is expected to grow at a CAGR of 5% during the forecast period 2023-2030.
Who are the key players in Hemophilia A Treatment Market ?
Major players are Takeda Pharmaceutical Company Limited, SANOFI CORPORATION, Genentech USA Inc, Novo Nordisk, Pfizer Inc, CSL Behring LLC, Grifols, Sagent Pharmaceuticals, Octapharma USA Inc, and UBI Pharma Inc.
Related Reports
pharmaceuticalsHemophilia Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
Starting from
$4350
pharmaceuticalsRare Haematology Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 07
Starting from
$4350
medical-devicesEurope Hematology Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 25
Starting from
$3750
pharmaceuticalsActivin A Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 28
Starting from
$4350
pharmaceuticalsChronic Eosinophilic Leukemia Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350
pharmaceuticalsBleeding Disorders Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 04
Starting from
$4350